Skip to main content

MW 523.7 Da, Purity >99%. Potent, ATP-competitive fibroblast growth factor receptor 1 (FGFR1) and FGFR3 inhibitor (IC50 values are 21.5 and 5 nM respectively). Shows little activity at EGFR, InsR, MEK and cPKC. Effectively inhibits angiogenesis in vivo. Also impairs tumor growth and inhibits self-renewal of stem cells.

Be the first to review this product! Submit a review

Images

Chemical Structure - PD 173074, FGFR1 and FGFR3 inhibitor (AB141117), expandable thumbnail
  • Functional Studies - PD 173074, FGFR1 and FGFR3 inhibitor (AB141117), expandable thumbnail

Publications

Key facts

CAS number

219580-11-7

Purity

> 99%

Form

Solid

Molecular weight

523.7 Da

Molecular formula

C28H41N7O3

PubChem identifier

1401

Nature

Synthetic

Alternative names

Recommended products

MW 523.7 Da, Purity >99%. Potent, ATP-competitive fibroblast growth factor receptor 1 (FGFR1) and FGFR3 inhibitor (IC50 values are 21.5 and 5 nM respectively). Shows little activity at EGFR, InsR, MEK and cPKC. Effectively inhibits angiogenesis in vivo. Also impairs tumor growth and inhibits self-renewal of stem cells.

Key facts

Purity

> 99%

PubChem identifier

1401

Solubility

Soluble in DMSO to 100 mM. Soluble in ethanol to 100 mM.

Biochemical name

1-(tert-Butyl)-3-(2-((4-(diethylamino)butyl)amino)-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)urea

Biological description

Potent, ATP-competitive fibroblast growth factor receptor 1 (FGFR1) and FGFR3 inhibitor (IC50 values are 21.5 and 5 nM respectively). Shows little activity at EGFR, InsR, MEK and cPKC. Effectively inhibits angiogenesis in vivo. Also impairs tumor growth and inhibits self-renewal of stem cells.

Canonical SMILES

CCN(CC)CCCCNC1=NC2=NC(=C(C=C2C=N1)C3=CC(=CC(=C3)OC)OC)NC(=O)NC(C)(C)C

InChI

InChI=1S/C28H41N7O3/c1-8-35(9-2)13-11-10-12-29-26-30-18-20-16-23(19-14-21(37-6)17-22(15-19)38-7)25(31-24(20)32-26)33-27(36)34-28(3,4)5/h14-18H,8-13H2,1-7H3,(H3,29,30,31,32,33,34,36)

InChIKey

DXCUKNQANPLTEJ-UHFFFAOYSA-N

IUPAC name

1-tert-butyl-3-[2-[4-(diethylamino)butylamino]-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]urea

Storage

Shipped at conditions

Ambient - Can Ship with Ice

Appropriate short-term storage conditions

+4°C

Appropriate long-term storage conditions

+4°C

Storage information

The product can be stored for up to 12 months

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.

Activity summary

Interferon beta Src Glucocorticoid Receptor CSK Estrogen Receptor VEGF Receptor 2 VEGF Receptor 1 Gli3 Androgen Receptor FGFR1 FGFR2 FGFR4 FGFR3 Yes1 and IDH1 represent proteins and receptors playing different mechanical roles. For instance FGFR1 known as Fibroblast Growth Factor Receptor 1 involves signaling pathways controlling cell division and differentiation; it possesses a mass of approximately 115 kDa. FGFR3 another receptor with similar functions is known for its variants like FGFR3 inhibitors impacting certain pathways. These proteins usually express across various tissues playing roles in development and maintenance.

Biological function summary

These targets and proteins serve roles in signal transduction and cellular response. They are part of complexes that help the body react to external signals. For example VEGF Receptors 1 and 2 contribute to angiogenesis and vascular maintenance. FGFR3 interacts with inhibitors influencing bone development and maintenance. Androgen and Estrogen Receptors modulate gene expression in response to hormonal signals affecting diverse physiological processes.

Pathways

Many of these proteins like Src and Yes1 integrate into significant signaling pathways. The MAPK and PI3K/AKT pathways involve multiple targets such as FGFR1 and Glucocorticoid Receptor contributing to cell growth and survival regulation. These pathways often interact with other proteins for coordinated cellular responses allowing complex regulation of different cellular functions.

Associated diseases and disorders

These proteins connect to certain pathologies through their involvement in critical pathways. For instance FGFR3 and its inhibitors relate to skeletal disorders like achondroplasia. Estrogen Receptor's interaction can link to breast cancer development often alongside Androgen Receptors influencing hormone-driven tumorous growths. Understanding their roles helps in developing targeted therapies for these conditions.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

2 product images

  • Chemical Structure - PD 173074, FGFR1 and FGFR3 inhibitor (ab141117), expandable thumbnail

    Chemical Structure - PD 173074, FGFR1 and FGFR3 inhibitor (ab141117)

    2D chemical structure image of ab141117, PD 173074, FGFR1 and FGFR3 inhibitor

  • Functional Studies - PD 173074, FGFR1 and FGFR3 inhibitor (ab141117), expandable thumbnail

    Functional Studies - PD 173074, FGFR1 and FGFR3 inhibitor (ab141117)

    BT549 cells were incubated at 37°C for 1 hour with vehicle control (0 μM) and different concentrations of PD 173074 (ab141117) in DMSO. Decreased expression of RSK1 p90 (phospho T359 + S363) Anti-RSK1 p90 (phospho T359) antibody [E238] ab32413 correlates with an increase in PD 173074 concentration, as described in literature.

    Whole cell lysates were prepared with RIPA buffer (containing protease inhibitors and sodium orthovanadate), 10 μg of each were loaded on the gel and the WB was run under reducing conditions. After transfer the membrane was blocked for an hour using 5% BSA before being incubated with Anti-RSK1 p90 (phospho T359) antibody [E238] ab32413 at 1/5000 dilution and Anti-beta Actin antibody ab8227 at 1 μg/ml overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP Goat Anti-Rabbit IgG H&L (HRP) ab97051 at 1/10000 dilution and visualised using ECL development solution.

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com